Mateja Pirs

Dr. Mateja Pirs


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2011 in Eurosurveillance
Verified
Journal Article
Open access
MPMateja Pirs
Mateja Pirs
AAA Andlovic
A Andlovic
TCT Cerar
T Cerar
TŽT Žohar-Čretnik
T Žohar-Čretnik
LKL Kobola
L Kobola
KSK Seme
K Seme
We report the first documented case of OXA-48-producing Klebsiella pneumoniae in Slovenia isolated from rectal surveillance cultures from a patient transferred from Libya. The patient was colonised with both ESBL-producing Escherichia coli and ESBL- and OXA-48-producing K. pneumoniae. Three further patients were colonised with ESBL-producing E. coli. This underscores the importance of an early warning system on European level and screening upon admission of patients transferred across borders and between healthcare systems.

22 September 2014 in Acta Dermatovenerologica Alpina Pannonica et Adriatica
Verified
Journal Article
Closed access
MPMateja Pirs
Mateja Pirs
BJBorut Jug
Borut Jug
BEBarbara Eržen
Barbara Eržen
MŠMišo Šabović
Mišo Šabović
PKPrimož Karner
Primož Karner
JTJanez Tomažič
Janez Tomažič
Traditional cardiovascular (CVD) risk assessment algorithms such as the Framingham Risk Score (FRS), Systematic Coronary Risk Evaluation (SCORE) and Prospective Cardiovascular Munster (PROCAM) were developed for general populations, their usefulness in HIV-infected population has not been confirmed. DAD algorithm was developed specifically for HIV-infected patients. The aim of our study was to evaluate the performance of risk assessment algorithms in HIV-infected population.

18 January 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
Deneke Wolde SolomonDeneke Wolde Solomon
Deneke Wolde Solomon
TETadesse Eguale
Tadesse Eguale
HGHaile Alemayehu Gezahegn
Haile Alemayehu Gezahegn
.M.Girmay Medhin
.Girmay Medhin
AHAklilu Feleke Haile
Aklilu Feleke Haile
MEMarjanca Starčič Erjavec
Marjanca Starčič Erjavec
Antimicrobial resistance of Escherichia coli is a growing problem in both developed and developing countries. This study aimed to investigate the phenotypic antimicrobial resistance of E. coli isolates (n = 260) isolated from the stool specimen of patients attending public health facilities in Addis Ababa and Hossana. This study also aimed to characterize phenotypically confirmed extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates (n = 22) using whole-genome sequencing. Resistance to 18 different antimicrobials was assessed using the disc diffusion method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. The highest resistance rate among the E. coli isolates was found for ampicillin (52.7%), followed by trimethoprim-sulfamethoxazole (29.6%). Of all isolates, 50 (19.2%) were multidrug-resistant and 22 (8.5%) were ESBL producers. ESBL genes were detected in 94.7% of the sequenced E. coli isolates, and multiple β-lactamase genes were detected in 57.9% of the isolates. The predominant ESBL gene identified was blaCTX-M-15 (78.9%). The blaTEM-1B gene was detected in combination with other ESBL genes in 57.9% of the isolates, while only one of the sequenced isolates contained the blaTEM-1B gene alone. The blaCTX-M-3 gene was detected in three isolates. The genes blaCTX-M-15 and blaTEM-1B as well as blaCTX-M-15 and blaTEM-169 were confirmed to coexist in 52.6% and 10.5% of the sequenced E. coli isolates, respectively. In addition, blaOXA-1 was identified together with blaCTX-M-15 and blaTEM-1B in one isolate, and in one isolate, blaTEM-169 together with blaCTX-M-15 and blaTEM-1B was found. The results obtained show that measures need to be taken to reduce the spread of drug resistance and ensure the long-term use of available antimicrobials.

31 March 2021 in Mycoses
Verified
Journal Article
Closed access
PDF file
TMTadeja Matos
Tadeja Matos
TZTatjana Lejko Zupanc
Tatjana Lejko Zupanc
ASAndreja Skofljanec
Andreja Skofljanec
AJAnja Jazbec
Anja Jazbec
EMErika Matos
Erika Matos
MPMateja Pirs
Mateja Pirs

1 September 2019 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
JGJulija Germ
Julija Germ
TKTjaša Cerar Kišek
Tjaša Cerar Kišek
BUBarbara Kokošar Ulčar
Barbara Kokošar Ulčar
TZTatjana Lejko Zupanc
Tatjana Lejko Zupanc
TMTatjana Mrvič
Tatjana Mrvič
MPMateja Pirs
Mateja Pirs
Purpose. Increasing consumption of colistin as treatment for infections with multidrug-resistant (MDR) Gram-negative bacilli (GNB) has been accompanied by increasingly frequent reports of colistin-resistant (ColR) MDR GNB. Higher selective pressure creates a favourable environment that can facilitate the spread of ColR isolates. Monitoring of asymptomatic ColR GNB carriage can give us a better understanding of this emerging healthcare problem, particularly in wards with higher polymyxin selective pressure and prevalence of carbapenem-resistant GNB. Our aim was to assess the ColR GNB colonization rate in intensive care unit (ICU) patients and evaluate the performance of two surveillance protocols using a selective medium. Methodology. A prospective study included 739 surveillance samples (rectal swabs and tracheal aspirates) from 330 patients that were screened for ColR GNB carriage using SuperPolymyxin medium. Two approaches were used: direct sample plating and overnight pre-enrichment of samples followed by plating. Colistin resistance was confirmed with broth microdilution. ColR isolates were molecularly screened for plasmid-mediated mcr genes. Results. A total of 44/739 samples (45 ColR GNB isolates) were positive for ColR GNB, which included 31/330 (9.4 %) colonized patients; mcr genes were not detected. The direct plating method only identified 17/45 (37.8 %) isolates correctly, whereas the pre-enrichment protocol identified all 45 ColR GNB. Conclusion. The colonization rate among our ICU patients was 9.4 %. Based on our findings, the pre-enrichment step is necessary for the determination of ColR GNB carriage – even though the time to result takes an additional day, fewer than half of ColR GNB carriers were detected using the direct plating protocol.

22 September 2014 in Acta Dermatovenerologica Alpina Pannonica et Adriatica
Verified
Journal Article
Closed access
MPMateja Pirs
Mateja Pirs
BJBorut Jug
Borut Jug
BEBarbara Eržen
Barbara Eržen
MŠMišo Šabović
Mišo Šabović
PKPrimož Karner
Primož Karner
JTJanez Tomažič
Janez Tomažič
Antiretroviral therapy in HIV-infected patients appears to be associated with increased incidence of cardiovascular disease (CVD).The aim of our study was to investigate the differences in markers of inflammation, endothelial dysfunction and prothrombotic state between treated and untreated HIV-infected patients with or without subclinical atherosclerosis.